NCR1 and neoplasm: Bispecific NKp46-Tag activate NK cells, but trispecific ANKET have greater potency for the activation of NK cells in vitro and for increasing the number of NK cells at the tumor site, thereby providing a higher degree of tumor growth control in solid and invasive mouse tumor models.